For instance, some researchers have designed small-molecule compounds targeting ILK to inhibit tumor growth, although these studies have neither clearly described whether these compounds directly bind to ILK nor demonstrated their specificity, which necessitates further exploration before their clinical application [24, 34–36]. Here, ILK is linked to neoplasm.